Paltusotine + Mao Inhibitors Interaction
Moderateinteraction on record
Description
Concomitant use demonstrates dose-dependent decrease in paltusotine exposure. Patients on PALSONIFY 60 mg should avoid concomitant use; others may require dosage increase.
Mechanism
Decreases paltusotine exposure in dose-dependent manner
Source: NLP:paltusotine